QVM149

Showing 1 posts of 1 posts found.

novartis_window

Investigational Novartis therapy smashes primary and secondary endpoints in uncontrolled asthma

May 30, 2019
Research and Development Novartis, QVM149, asthma, pharma

Novartis has announced the first findings on the efficacy of its investigational asthma therapy QVM149 in the treatment of inadequately …

The Gateway to Local Adoption Series

Latest content